Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
MURRAY JAMES E
   2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [HUM] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP & COO
(Last)
(First)
(Middle)
HUMANA INC., 500 WEST MAIN STREET		 3. Date of Earliest Transaction (Month/Day/Year)
03/30/2012
(Street)

LOUISVILLE, KY 40202		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Humana Common               3,983 I See Footnote (1)
Humana Common 03/30/2012   M   67,042 A $ 62.1 177,467 D  
Humana Common 03/30/2012   M   32,439 A $ 69.475 209,906 D  
Humana Common 03/30/2012   M   33,327 A $ 41.83 243,233 D  
Humana Common 03/30/2012   M   19,042 A $ 46.4 262,275 D  
Humana Common 03/30/2012   M   13,069 A $ 61.18 275,344 D  
Humana Common 03/30/2012   F   102,918 D $ 92.245 172,426 D  
Humana Common 03/30/2012   F   26,372 D $ 92.245 146,054 D  
Humana Common 03/30/2012   S   5,000 D $ 92.8 (17) 141,054 D  
Humana Common 03/30/2012   S   32,000 D $ 92.907 (18) 109,054 D  
Humana Common 03/30/2012   S   1,000 D $ 92.863 (19) 108,054 D  
Humana Common 03/30/2012   G   269 D $ 92.245 107,785 D  
Humana Common               1,356 I See Footnote (2)
Humana Common               25,072 I See Footnote (3)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options (4) $ 62.1 03/30/2012   M     67,042   (5) 02/22/2014 Humana Common 67,042 $ 62.1 0 D  
Options (4) $ 69.475 03/30/2012   M     32,439   (6) 02/21/2015 Humana Common 32,439 $ 69.475 38,234 D  
Options (4) $ 41.83 03/30/2012   M     33,327   (7) 02/19/2016 Humana Common 33,327 $ 41.83 0 D  
Options (4) $ 46.4 03/30/2012   M     19,042   (8) 02/18/2017 Humana Common 19,042 $ 46.4 19,042 D  
Options (4) $ 61.18 03/30/2012   M     13,069   (9) 02/17/2018 Humana Common 13,069 $ 61.18 26,140 D  
Options (4) $ 88.6475               (10) 02/23/2019 Humana Common 48,747   48,747 D  
Restricted Stock Units (11) (12)               (13)   (13) Humana Common 8,867   8,867 D  
Restricted Stock Units (11) (12)               (14)   (14) Humana Common 28,668   28,668 D  
Restricted Stock Units (11) (12)               (15)   (15) Humana Common 9,476   9,476 D  
Phantom Stock Units (16) 03/30/2012   J   78     (16)   (16) Humana Common 78 $ 89.02 29,475 I See Footnote (16)

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
MURRAY JAMES E
HUMANA INC.
500 WEST MAIN STREET
LOUISVILLE, KY 40202		       EVP & COO  

Signatures

 James E. Murray   04/03/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Shares held by reporting person's spouse.
(2) Shares held in The Murray Family trust.
(3) Stock units held for the benefit of reporting person as of March 30, 2012 under the Humana Retirement & Savings Plan, including a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan. All transactions are exempt under Rule 16b-3(c).
(4) Right to buy pursuant to Company's 2003 Stock Incentive Plan.
(5) Incentive and Non-Qualified stock options granted to reporting person on 2/22/07, NQ options vesting in three increments from 2/22/08 to 2/22/10, and ISO's vesting on 2/22/10.
(6) Incentive and Non-Qualified stock options granted to reporting person on 2/21/08, NQ options vesting in three increments from 2/21/09 to 2/21/11, and ISO's vesting on 2/21/11.
(7) Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/19/10 to 2/19/12.
(8) Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/18/11 to 2/18/13.
(9) Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/17/12 to 2/17/14.
(10) Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/23/13 to 2/23/15.
(11) Right to receive one share per restricted stock unit pursuant to the Company's 2003 Stock Incentive Plan.
(12) Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
(13) Restricted stock units granted to reporting person on 2/17/11, 100% of the award is vesting on 2/17/14.
(14) Restricted stock units granted to reporting person on 11/7/11, 100% of the award is vesting on 11/7/13.
(15) Restricted stock units granted to reporting person on 2/23/12, 100% of the award is vesting on 2/23/15.
(16) Phantom Stock Units held for the benefit of reporting person as of March 30, 2012 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Excess Plan. 78 shares were acquired for a quarterly allocation of dividends under the Plan using the closing price of the dividend payable date on January 31, 2012. (The number of units reflect normal fluctuation due to changes in the stock price)
(17) This price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $92.80 to $92.81. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.
(18) This price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $92.515 to $93.01. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.
(19) This price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $92.851 to $92.892. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.